LitCovid-sample-Enju  

PMC:7253482 / 25933-26258 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T60855 0-2 IN denotes In
T15145 3-11 NN denotes contrast
T83757 11-12 -COMMA- denotes ,
T41451 13-16 DT denotes the
T95094 17-21 JJ denotes high
T76290 22-30 NN denotes mutation
T92271 31-37 NN denotes rate66
T59290 38-41 CC denotes and
T46337 42-45 DT denotes the
T52476 46-54 VBG denotes evolving
T10675 55-61 NN denotes glycan
T18714 62-68 NN denotes shield
T37792 69-71 IN denotes of
T21845 72-82 NN denotes HIV-120,39
T87196 82-83 -COMMA- denotes ,
T16269 84-89 WDT denotes which
T23317 90-96 RB denotes firmly
T90485 97-108 VBZ denotes exemplifies
T49535 109-111 PRP denotes it
T16896 112-114 IN denotes as
T63209 115-123 NN denotes “evasion
T42025 124-131 NN denotes strong”
T63465 132-137 NN denotes virus
T4468 137-138 -COMMA- denotes ,
T1830 139-146 VBZ denotes hinders
T56636 147-150 DT denotes the
T80263 151-162 NN denotes development
T21297 163-165 IN denotes of
T77941 166-173 RB denotes broadly
T47145 174-186 VBG denotes neutralizing
T48978 187-207 NNS denotes antibodies67.Viruses
T78349 208-218 VBN denotes classified
T84508 219-221 IN denotes as
T99687 222-230 NN denotes “evasion
T94485 231-243 NN denotes strong”26,56
T8371 244-247 MD denotes may
T70765 248-252 RB denotes then
T19557 253-259 VB denotes differ
T68211 260-263 JJ denotes due
T58964 264-266 TO denotes to
T91845 267-273 JJ denotes varied
T28724 274-284 NNS denotes efficacies
T35775 285-287 IN denotes of
T42494 288-295 NN denotes protein
T48391 296-303 NN denotes surface
T91764 304-313 NN denotes shielding
T1369 314-316 IN denotes by
T1370 317-324 NNS denotes glycans
R13160 T63465 T42025 arg1Of virus,strong”
R1386 T48978 T21297 arg2Of antibodies67.Viruses,of
R1387 T47145 T77941 arg1Of neutralizing,broadly
R1388 T48978 T47145 arg1Of antibodies67.Viruses,neutralizing
R1389 T48978 T78349 arg2Of antibodies67.Viruses,classified
R1390 T78349 T84508 arg1Of classified,as
R1391 T94485 T84508 arg2Of "strong”26,56",as
R1392 T94485 T99687 arg1Of "strong”26,56",“evasion
R1393 T80263 T8371 arg1Of development,may
R1394 T19557 T8371 arg2Of differ,may
R1395 T19557 T70765 arg1Of differ,then
R1396 T80263 T19557 arg1Of development,differ
R1397 T58964 T68211 arg1Of to,due
R1398 T19557 T58964 arg1Of differ,to
R1399 T28724 T58964 arg2Of efficacies,to
R1400 T28724 T91845 arg1Of efficacies,varied
R1402 T91764 T35775 arg2Of shielding,of
R1403 T91764 T42494 arg1Of shielding,protein
R1404 T91764 T48391 arg1Of shielding,surface
R1406 T1370 T1369 arg2Of glycans,by
R18543 T92271 T41451 arg1Of rate66,the
R20306 T28724 T35775 arg1Of efficacies,of
R22078 T91764 T1369 arg1Of shielding,by
R24584 T18714 T59290 arg2Of shield,and
R37843 T18714 T10675 arg1Of shield,glycan
R38925 T18714 T87196 arg1Of shield,","
R44853 T90485 T16896 arg1Of exemplifies,as
R46559 T18714 T16269 arg1Of shield,which
R46661 T63465 T16896 arg2Of virus,as
R55292 T80263 T21297 arg1Of development,of
R57447 T15145 T60855 arg2Of contrast,In
R59613 T18714 T37792 arg1Of shield,of
R63988 T1830 T4468 arg1Of hinders,","
R69771 T21845 T37792 arg2Of "HIV-120,39",of
R70746 T1830 T60855 arg1Of hinders,In
R7092 T92271 T59290 arg1Of rate66,and
R71846 T19557 T1830 arg2Of differ,hinders
R72489 T18714 T46337 arg1Of shield,the
R76166 T18714 T52476 arg1Of shield,evolving
R78632 T90485 T23317 arg1Of exemplifies,firmly
R80497 T18714 T90485 arg1Of shield,exemplifies
R81667 T63465 T63209 arg1Of virus,“evasion
R82201 T1830 T83757 arg1Of hinders,","
R82299 T59290 T1830 arg1Of and,hinders
R82405 T49535 T90485 arg2Of it,exemplifies
R8642 T92271 T76290 arg1Of rate66,mutation
R93165 T80263 T56636 arg1Of development,the
R93264 T92271 T95094 arg1Of rate66,high